Chris Scanlan

Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity

Margaret E. Ackerman, Max Crispin, Xiaojie Yu et al. · Journal of Clinical Investigation · 2013 · 353 citations · Full text

Natural Variation, Humoral Response, Immunology +20

Impact of Immune Complex Size and Glycosylation on IgG Binding to Human FcγRs

Anja Lux, Xiaojie Yu, Chris Scanlan et al. · The Journal of Immunology · 2013 · 266 citations

Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function

Amy W. Chung, Max Crispin, Laura K. Pritchard et al. · AIDS · 2014 · 118 citations · Full text

Differentiation between isomeric triantennary <i>N</i> ‐linked glycans by negative ion tandem mass spectrometry and confirmation of glycans containing galactose attached to the bisecting ( <i>β</i> 1‐4‐GlcNAc) residue in <i>N</i> ‐glycans from IgG

David J. Harvey, Max Crispin, Chris Scanlan et al. · Rapid Communications in Mass Spectrometry · 2008 · 52 citations

A peptide inhibitor of HIV‐1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120

Alfredo Menéndez, D.A. Calarese, Robyn L. Stanfield et al. · The FASEB Journal · 2008 · 33 citations · Full text

Crystal Structure, Glycobiology, Immunology +18